Already 8,154 people have seen this company's branding and they are being followed by 158 Storybook user.In average the company has been rated 5.0 points ja kommenteeritud 1 kord.

's activity report 2022

AS Semetron Consolidation Group operates as a seller and maintenance service provider of medical devices and accessories. AS Semetron Consolidation Group mainly operated in Estonia during the reporting year. During the reporting year, a new subsidiary MM Hospital OÜ was established, which aims to sell mobile military hospitals in foreign markets. As of 30.04.2023, the Consolidation Group includes the Lithuanian company Semetron UAB and the Latvian company Semetron SIA.

The main clients of the Consolidation Group are healthcare institutions and the Defense Forces. Most

Baltic national health institutions are financed by the local Health Insurance Fund. Despite the fact that private capital investments in this sector are increasing every year, the majority of this market is held by Estonian public health institutions. This factor in turn makes the sector directly dependent on the state's financial situation. In 2022, the economic environment in Estonia and the whole world was challenging. The economic environment was mainly affected by the war in Ukraine, rapid growth of energy prices, high inflation rate, and increased interest rates.

Foreign environment (geopolitical) instability has significantly affected the business purchase side (delivery times and purchase prices), while growth was only seen in some segments on the sales side (disaster medicine products).

The turnover of AS Semetron Consolidation Group for the financial year ended 30.04.2023 was 30.7 million EUR (turnover on 30.04.2022 was 20.7 million EUR). 98% of the total turnover is made up of the sale of medical devices and accessories (also 98% of turnover on 30.04.2022), the remaining part is made up of the maintenance and repair service of the mentioned devices.

The volume of fixed asset investments in the financial year ended 30.04.2023 was 41,503 EUR in terms of tangible fixed assets (volume on 30.04.2022 was 21,280 EUR) and 148,512 EUR in terms of intangible fixed assets (volume on 30.04.2022 was 204,029 EUR).

Development costs in the financial year ended 30.04.2023 amounted to 76,574 EUR (amount on 30.04.2022 was 155,130 EUR). Development costs and the majority of the acquisition of intangible fixed assets are related to the development of the military hospital information system and the development of military hospital container solutions.

The goal for the following year is to maintain the sales results of the financial year ended 30.04.2023